⌘K

16:15:06·1042d

13D/GFilingvia Quantisnow

SEC Form SC 13G filed by Praxis Precision Medicines Inc.

ByQuantisnow·Wall Street's wire, on your screen.

PRAX· Praxis Precision Medicines Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

PRAX
Praxis Precision Medicines Inc.
Health Care

Recent analyst ratings

Apr 10UpdateRaymond James$815.00
Feb 24UpdateWolfe Research$500.00
Feb 2UpdateWells Fargo$282.00
Dec 15UpdateOppenheimer$750.00
Nov 19UpdateBTIG Research$424.00
Jun 2UpdateOppenheimer$97.00

Related

SEC21h
SEC Form 10-Q filed by Praxis Precision Medicines Inc.
PR22h
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
SEC1d
Amendment: SEC Form SCHEDULE 13G/A filed by Praxis Precision Medicines Inc.
PR2d
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR3d
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
SEC7d
SEC Form DEFA14A filed by Praxis Precision Medicines Inc.
SEC7d
SEC Form DEF 14A filed by Praxis Precision Medicines Inc.
SEC23d
Praxis Precision Medicines Inc. filed SEC Form 8-K: Other Events

SEC Form SC 13G filed by Praxis Precision Medicines Inc. | Quantisnow